Today we have a BIG new! We want to announce that the protocol and documents for the phase II clinical trial of … [Read more...] about The phase II clinical trial protocol and documents have been submitted!
We are Catalonia BioHT!
The video presentation of Oxolife as a new member of CataloniaBio Health Tech has already come to light. We are very … [Read more...] about We are Catalonia BioHT!
OXOLIFE will participate in the ESHRE 37th Annual Meeting
At the end of June, the European Society of Human Reproduction and Embryology (ESHRE) organizes its 37th Annual Meeting … [Read more...] about OXOLIFE will participate in the ESHRE 37th Annual Meeting
OXOLIFE AND IBEC START AN STRATEGIC ALLIANCE TO STUDY OXO-001 IMPLANTATION ACTIVITY
Fresh news! Today it has been published in La Vanguardia the collaboration between OXOLIFE and the Open Innovation … [Read more...] about OXOLIFE AND IBEC START AN STRATEGIC ALLIANCE TO STUDY OXO-001 IMPLANTATION ACTIVITY
BIOTECH COMPANY OXOLIFE AND UNIVERSITY OF CORDOBA ARE TESTING A NEW DRUG TO IMPROVE FERTILITY IN WOMEN WITH POLYCYSTIC OVARY
Oxolife has established a collaboration with the Energy Balance, Puberty and Reproductive Health Group of the University … [Read more...] about BIOTECH COMPANY OXOLIFE AND UNIVERSITY OF CORDOBA ARE TESTING A NEW DRUG TO IMPROVE FERTILITY IN WOMEN WITH POLYCYSTIC OVARY
OXOLIFE RECEIVES SEAL OF EXCELLENCE FROM THE EUROPEAN COMMISSION
OXOLIFE is celebrating. The European Commission has awarded us with the “Seal of Excellence” for our … [Read more...] about OXOLIFE RECEIVES SEAL OF EXCELLENCE FROM THE EUROPEAN COMMISSION